East Sussex Healthcare NHS Trust

Specialist MDT: Brighton and Sussex University Hospitals NHS Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Chemotherapy
    • Joint specialist MDT clinic
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling

Data Quality

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 405 405
Performance Status recorded 74% 74%
PSA completed 87% 87%
Gleason Score completed 75% 75%
TNM completed 81% 81%

Disease Presentation

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men with disease status determined 377 39897
Percentage of men diagnosed with metastatic disease 18% 17%

Management

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men diagnosed with low-risk localised disease 64 4684
Percentage of men with low-risk localised disease receiving radical treatment 8% 8%
No. of men diagnosed with locally advanced disease 157 15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment 59% 68%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (April 2022- March 2023) 176
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 11%
No. of men who received radical prostatectomy (September 2020 - August 2021) 123
Adjusted percentage of men experiencing at least one GU complication (%) 3%

Compare provider outcomes